BEKSAÇ, M. Et Al. 2002. Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation. A single institutional experience.. 44th Annual Meeting of the American-Society-of-Hematology , (PHILADELPHIA, PENNSYLVANIA).

BEKSAÇ, M., Arat, M., Dalva, K., Ilhan, O., GÜRMAN, G., Ozcan, M., ... Arslan, O.(2002). Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation. A single institutional experience. . 44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA

BEKSAÇ, MERAL Et Al. "Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation. A single institutional experience.," 44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 2002

BEKSAÇ, MERAL Et Al. "Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation. A single institutional experience.." 44th Annual Meeting of the American-Society-of-Hematology , PHILADELPHIA, PENNSYLVANIA, 2002

BEKSAÇ, M. Et Al. (2002) . "Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation. A single institutional experience.." 44th Annual Meeting of the American-Society-of-Hematology , PHILADELPHIA, PENNSYLVANIA.

@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation. A single institutional experience.}, congress name={44th Annual Meeting of the American-Society-of-Hematology}, city={PHILADELPHIA}, country={PENNSYLVANIA}, year={2002}}